Your browser doesn't support javascript.
loading
Reduced-toxicity conditioning for allogeneic hematopoietic cell transplantation in elderly or comorbid patients with AML using fludarabine, BCNU and melphalan: disease stage at transplant determines outcome.
Wais, V; Kündgen, L; Bohl, S R; von Harsdorf, S; Schlenk, R F; Döhner, K; Teleanu, V; Bullinger, L; Nguyen, T M; Drognitz, K; Moulin, J-C; Binnenhei, M; Bentz, M; Döhner, H; Bunjes, D; Kuchenbauer, F; Ringhoffer, M.
Afiliación
  • Wais V; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Kündgen L; Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
  • Bohl SR; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • von Harsdorf S; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Schlenk RF; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Döhner K; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Teleanu V; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Bullinger L; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Nguyen TM; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Drognitz K; Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
  • Moulin JC; Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
  • Binnenhei M; Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
  • Bentz M; Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
  • Döhner H; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Bunjes D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Kuchenbauer F; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Ringhoffer M; Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany.
Bone Marrow Transplant ; 53(1): 94-96, 2018 01.
Article en En | MEDLINE | ID: mdl-29131153
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante Homólogo / Vidarabina / Carmustina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Melfalán Límite: Aged / Female / Humans / Male Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante Homólogo / Vidarabina / Carmustina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Melfalán Límite: Aged / Female / Humans / Male Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Alemania